Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, signaling a new version of the page content.
    Difference
    0.0%
    Check dated 2026-07-04T13:26:21.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This represents a new build of the page without altering the study data or content.
    Difference
    0.0%
    Check dated 2026-06-27T06:29:44.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants'. New help sections were added to guide users on reading the study record and joining the study, and the Intervention/Treatment label was updated.
    Difference
    0.4%
    Check dated 2026-06-13T05:17:13.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a newer page rendering. This appears to be a minor metadata update rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-06-05T23:50:13.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new platform revision label Revision: v3.5.4 was added, replacing the previous Revision: v3.5.3. This indicates a backend deployment update with no change to the page content or study details.
    Difference
    0.0%
    Check dated 2026-05-15T13:51:51.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:09:59.000Z thumbnail image

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.